Skip to main content

Industries - Life Sciences

Pharmaceutical

Pharmaceutical

Pharmaceutical organizations are prime targets for cyberattacks due to the wealth of valuable information they possess. From groundbreaking research and development data to intellectual property and sensitive patient information, these organizations hold a treasure trove of data that cybercriminals seek to exploit. The pharmaceutical industry's focus on innovation and the development of life-saving medications makes it an attractive target for those looking to gain a competitive advantage, steal trade secrets, or profit from the illicit sale of stolen medical data. The growing digitalization of the industry, with increased reliance on interconnected systems and cloud-based platforms, has expanded the attack surface and heightened the vulnerability of pharmaceutical organizations to cyber threats.

$5.01 million

The combined average cost of a data breach for pharmaceutical and biomedical organizations

(2022 Cost of a Data Breach Report by IBM Security)

40%

of pharmaceutical organizations surveyed experienced outages that affected productivity, safety, compliance, revenue, or brand image.

(2021 State of Pharmaceuticals and Cybersecurity Report by Fortinet)

28%

of pharmaceutical firms surveyed lost business-critical data or Intellectual Property (IP).

(2021 State of Pharmaceuticals and Cybersecurity Report by Fortinet)

At FourCorners Cyber, we understand the unique cybersecurity challenges faced by pharmaceutical organizations, and are committed to providing tailored solutions to mitigate these risks. Our team of experienced cybersecurity experts specializes in working with pharmaceutical clients to develop robust defense strategies and safeguard valuable assets and offer comprehensive services to enhance overall security posture. By partnering with FourCorners Cyber, pharmaceutical organizations can gain access to cutting-edge technologies, proactive threat monitoring, and expert guidance to stay ahead of emerging cyber threats.